ym 16151-1 has been researched along with atenolol in 3 studies
| Studies (ym 16151-1) | Trials (ym 16151-1) | Recent Studies (post-2010) (ym 16151-1) | Studies (atenolol) | Trials (atenolol) | Recent Studies (post-2010) (atenolol) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 5,473 | 1,950 | 852 |
| Protein | Taxonomy | ym 16151-1 (IC50) | atenolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.7468 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, M; Shibasaki, K; Uchida, W | 1 |
| Berdeaux, A; Drieu la Rochelle, C; Giudicelli, JF; Richard, V | 1 |
| Asano, M; Matsuda, Y; Shibasaki, K; Takenaka, T; Uchida, W | 1 |
3 other study(ies) available for ym 16151-1 and atenolol
| Article | Year |
|---|---|
Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Atenolol; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Female; Heart Conduction System; Heart Rate; Hemodynamics; Male; Nifedipine; Nitrophenols; Vagotomy; Vasodilator Agents | 1992 |
Coronary effects of a combined beta adrenoceptor blocking and calcium antagonist therapy in running dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Dogs; Hemodynamics; Nicardipine; Nitrophenols; Running | 1991 |
Cardiovascular effects of YM-16151-4: a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent in rats and dogs.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dogs; Heart Rate; Hemodynamics; Male; Nifedipine; Nitrophenols; Rats; Rats, Wistar; Renin | 1993 |